(600222)"Henan Taloph Pharmaceutical Stock Co., Ltd."Announcement on Approval of Registration for Medium-term Notes
Filed with SSE · Stock code 600222 · · 2 pages · Chinese
Summary by 6ix AI
Henan Taloph Pharmaceutical Stock Co. Ltd. has announced the approval for the registration of medium-term notes.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Henan Taloph Pharmaceutical Stock Co. Ltd. on 6ix
Story so far
Earlier from Henan Taloph Pharmaceutical Stock
- Announcement on Progress in Providing Guarantee for the Financing of Wholly-owned Subsidiary
- Announcement on Successive Freezing of Shares Held by Shareholder Holding More Than 5% of the Shares
- Announcement on Change in Accounting Policies
- Announcement on Completion of Redemption of the 1st Tranche of Super Short-Term Commercial Paper for 2026
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Henan Taloph Pharmaceutical Stock into a list and get an email when it puts out news.
Follow Henan Taloph Pharmaceutical Stock